FR2464269B1 - NUCLEOTIDE SEQUENCE ENCODING HEPATITIS B VIRUS SURFACE ANTIGEN, PROCESS FOR OBTAINING SAME AND ANTIGEN OBTAINED - Google Patents

NUCLEOTIDE SEQUENCE ENCODING HEPATITIS B VIRUS SURFACE ANTIGEN, PROCESS FOR OBTAINING SAME AND ANTIGEN OBTAINED

Info

Publication number
FR2464269B1
FR2464269B1 FR7921811A FR7921811A FR2464269B1 FR 2464269 B1 FR2464269 B1 FR 2464269B1 FR 7921811 A FR7921811 A FR 7921811A FR 7921811 A FR7921811 A FR 7921811A FR 2464269 B1 FR2464269 B1 FR 2464269B1
Authority
FR
France
Prior art keywords
antigen
nucleotide sequence
sequence encoding
virus surface
obtaining same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7921811A
Other languages
French (fr)
Other versions
FR2464269A1 (en
Inventor
Francis Galibert
Pierre Tiollais
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7921811A priority Critical patent/FR2464269B1/en
Priority to FR8009039A priority patent/FR2480779B2/en
Priority to PCT/FR1980/000133 priority patent/WO1981000577A1/en
Priority to BE0/201915A priority patent/BE884988A/en
Priority to DE19803049831 priority patent/DE3049831C2/en
Priority to CH5138780A priority patent/CH666278A5/en
Priority to NL8020315A priority patent/NL192880C/en
Priority to JP55501975A priority patent/JPS6362198B2/ja
Priority to CA000359303A priority patent/CA1163585A/en
Priority to US06/261,199 priority patent/US4428941A/en
Priority to GB8113283A priority patent/GB2070621B/en
Priority to CH2854/81A priority patent/CH663796A5/en
Publication of FR2464269A1 publication Critical patent/FR2464269A1/en
Priority to SE8102726D priority patent/SE8102726L/en
Priority to SE8102726A priority patent/SE463459B/en
Priority to SE8303463A priority patent/SE462530B/en
Priority to CA000445905A priority patent/CA1203763A/en
Application granted granted Critical
Publication of FR2464269B1 publication Critical patent/FR2464269B1/en
Priority to JP62106154A priority patent/JPS6345227A/en
Priority to US07/640,494 priority patent/USRE34705E/en
Priority to LU88365C priority patent/LU88365I2/en
Priority to US08/369,998 priority patent/US6096879A/en
Priority to US08/478,853 priority patent/US6416996B1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7921811A 1978-12-18 1979-08-30 NUCLEOTIDE SEQUENCE ENCODING HEPATITIS B VIRUS SURFACE ANTIGEN, PROCESS FOR OBTAINING SAME AND ANTIGEN OBTAINED Expired FR2464269B1 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
FR7921811A FR2464269B1 (en) 1979-08-30 1979-08-30 NUCLEOTIDE SEQUENCE ENCODING HEPATITIS B VIRUS SURFACE ANTIGEN, PROCESS FOR OBTAINING SAME AND ANTIGEN OBTAINED
FR8009039A FR2480779B2 (en) 1979-08-30 1980-04-22 VECTOR CONTAINING A NUCLEOTIDE SEQUENCE OF THE SURFACE ANTIGEN OF HEPATITIS B VIRUS AND METHOD FOR MANUFACTURING AN IMMUNOGENIC MOLECULE USING THE SAME
BE0/201915A BE884988A (en) 1979-08-30 1980-08-29 NUCLEOTIDE SEQUENCE, VECTOR CONTAINING SAID NUCLEOTIDE SEQUENCE, METHOD FOR PROVIDING SAME AND ANTIGEN OBTAINED
DE19803049831 DE3049831C2 (en) 1979-08-30 1980-08-29 Vectors containing a nucleotide sequence coding for the surface antigen of the hepatites B virus, use of these vectors for the production of peptides, vaccines containing peptides thereby obtained as antigen
CH5138780A CH666278A5 (en) 1979-08-30 1980-08-29 Nucleic acid coding for hepatitis B antigen
NL8020315A NL192880C (en) 1979-08-30 1980-08-29 Nucleic acid encoding the surface antigen of a Hepatitis B virus, peptide encoding it, vector containing the nucleic acid, hybrid protein encoding the nucleic acid inserted into the vector, and vaccine containing the hybrid protein.
JP55501975A JPS6362198B2 (en) 1979-08-30 1980-08-29
CA000359303A CA1163585A (en) 1979-08-30 1980-08-29 Nucleotidic sequence coding the surface antigen of the hepatitis b virus, carrier containing the nucleotidic sequence, preparation process and antigen so obtained
US06/261,199 US4428941A (en) 1979-08-03 1980-08-29 Nucleotidic sequence coding the surface antigen of the hepatitis B virus, vector containing said nucleotidic sequence, process allowing the obtention thereof and antigen obtained thereby
GB8113283A GB2070621B (en) 1979-08-30 1980-08-29 Nucleotidic sequence coding the surface antigen of the hepatitis b virus vector containing said nucleotidic sequence process allowing the obtention thereof and antigen obtained thereby
PCT/FR1980/000133 WO1981000577A1 (en) 1979-08-30 1980-08-29 Nucleotidic sequence coding the surface antigen of the hepatitis b virus,vector containing said nucleotidic sequence,process allowing the obtention thereof and antigen obtained thereby
CH2854/81A CH663796A5 (en) 1979-08-30 1980-08-29 NUCLEIC ACID ENCODING FOR AN IMMUNOGENIC PEPTIDE SEQUENCE CONTAINED IN THE SURFACE ANTIGEN OF HEPATITIS B VIRUS AND ITS USE FOR MODIFYING VECTORS.
SE8102726D SE8102726L (en) 1979-08-30 1981-04-29 NUCLEOTID SEQUENCE CODING THE SURFACE ANTIGEN OF HEPATIT B VIRUS, VECTOR INCLUDING THE NUCLEOTID SEQUENCE, PROCEDURE OF RECOVERY THEREOF, AND RECOVERY OF ANTIGEN
SE8102726A SE463459B (en) 1979-08-30 1981-04-29 VECTOR INCLUDING CODENCING DNA SEQUENCE FOR A SURFACE Hepatitis B Virus
SE8303463A SE462530B (en) 1979-08-30 1983-06-16 IMMUNOGENEOUS PEPTIDES INducing VIVO PRODUCTION OF ACTIVE ANTIBODIES WITH REGARD TO HEPATIT B VIRUSES
CA000445905A CA1203763A (en) 1979-08-30 1984-01-23 Hydrid protein coded by a dna fragment
JP62106154A JPS6345227A (en) 1979-08-30 1987-04-28 Hepatitis b virus surface antigen protein
US07/640,494 USRE34705E (en) 1979-08-30 1991-01-14 Nucleotidic sequence coding the surface antigen of the hepatitis B virus, vector containing said nucleotidic sequence, process allowing the obtention thereof and antigen obtained thereby
LU88365C LU88365I2 (en) 1979-08-30 1993-07-02 Hbvax recombinant vaccine containing HBsAG protein for active immunization against hepatitis B infections.
US08/369,998 US6096879A (en) 1978-12-18 1995-01-09 Nucleotide sequence comprising the genome of hepatitis B virus, nucleotide sequence coding the surface antigen of the hepatitis B virus, vectors containing the nucleotide sequences, process for the preparation thereof, and antigen obtained thereby
US08/478,853 US6416996B1 (en) 1978-12-18 1995-06-07 Nucleotide sequence comprising the genome of hepatitis b virus, nucleotide sequence coding the surface antigen of the hepatitis b virus, vectors containing the nucleotide sequences, process for the preparation thereof, and antigen obtained thereby

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7921811A FR2464269B1 (en) 1979-08-30 1979-08-30 NUCLEOTIDE SEQUENCE ENCODING HEPATITIS B VIRUS SURFACE ANTIGEN, PROCESS FOR OBTAINING SAME AND ANTIGEN OBTAINED

Publications (2)

Publication Number Publication Date
FR2464269A1 FR2464269A1 (en) 1981-03-06
FR2464269B1 true FR2464269B1 (en) 1986-04-18

Family

ID=9229230

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7921811A Expired FR2464269B1 (en) 1978-12-18 1979-08-30 NUCLEOTIDE SEQUENCE ENCODING HEPATITIS B VIRUS SURFACE ANTIGEN, PROCESS FOR OBTAINING SAME AND ANTIGEN OBTAINED

Country Status (2)

Country Link
JP (1) JPS6345227A (en)
FR (1) FR2464269B1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE34705E (en) * 1979-08-30 1994-08-23 Institut Pasteur Nucleotidic sequence coding the surface antigen of the hepatitis B virus, vector containing said nucleotidic sequence, process allowing the obtention thereof and antigen obtained thereby
FR2767337B1 (en) 1997-08-14 2002-07-05 Pasteur Institut NUCLEIC SEQUENCES OF POLYPEPTIDES EXPORTED FROM MYCOBACTERI ES, VECTORS COMPRISING THEM AND APPLICATIONS TO DIAGNOSIS AND THE PREVENTION OF TUBERCULOSIS
FR2772047B1 (en) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E GENOMIC SEQUENCE AND POLYPEPTIDES OF CIRCOVIRUS ASSOCIATED WITH PIGLET LOSS DISEASE (MAP), APPLICATIONS TO DIAGNOSIS AND TO PREVENTION AND / OR TREATMENT OF INFECTION
JP7164598B2 (en) 2017-05-17 2022-11-01 サンダー・バイオテック・インコーポレイテッド Transgenic macrophages, chimeric antigen receptors, and related methods

Also Published As

Publication number Publication date
JPS6345227A (en) 1988-02-26
FR2464269A1 (en) 1981-03-06

Similar Documents

Publication Publication Date Title
BE884988A (en) NUCLEOTIDE SEQUENCE, VECTOR CONTAINING SAID NUCLEOTIDE SEQUENCE, METHOD FOR PROVIDING SAME AND ANTIGEN OBTAINED
BE888534A (en) Immunological analysis method.
DE69111538D1 (en) Process for stabilizing complex shaped preforms.
DE3765887D1 (en) METHOD FOR CLOTHING OPTICAL PREFORMS WITH GLASS.
DE69006951D1 (en) Process for the preparation of 1,1,1,2-tetrafluoroethane.
DE3779268D1 (en) GLASS OBJECT PRODUCED FROM A GEL MOLDED WITH THE AID OF GAS, AND METHOD FOR PRODUCING THIS OBJECT.
DE3774247D1 (en) TETRAFLUORETHYLENE POLYMERIZATION PROCESS.
DE69008659D1 (en) Condensate cleaning process.
AT375378B (en) METHOD FOR PRODUCING 4'-DEOXYDAUNORUBICIN
DE69010048D1 (en) Process for the production of bulky nonwovens.
DE69009614D1 (en) Process for the preparation of (S) -gamma-hydroxymethyl-alpha, beta-butenolide.
RO83129A (en) PROCESS FOR PREPARING 5,6,7,7A-TETRAHYDRO-4H-THINO (3,2-C) PYRIDIN-2-OVA
DE68907735D1 (en) GENE FRAGMENTS ENCODING THE VARIABLE REGION OF AN ANTI-HIV ANTIBODY, CHIMERA ANTI-HIV ANTIBODIES EXPRESSED BY THESE, AND METHOD FOR THE PRODUCTION THEREOF.
FR2464269B1 (en) NUCLEOTIDE SEQUENCE ENCODING HEPATITIS B VIRUS SURFACE ANTIGEN, PROCESS FOR OBTAINING SAME AND ANTIGEN OBTAINED
AT366699B (en) METHOD FOR PRODUCING 3 '', 4 '' DIACYLTYLOSIN DERIVATIVES
AT367739B (en) METHOD FOR PRODUCING 2 ', 6'-DIALKYL-N (ALKOXYMETHYL) -2-CHLORACETANILIDES
IT8348154A0 (en) T-CELL LEUKEMIA ANTIGENS IN ADULTS, METHODS FOR THEIR PRODUCTION TO TESTING ANTIBODY FOR THESE
DE68904825D1 (en) NON-AQUEOUS PROCESS FOR PRODUCING ALUMOXANS.
ATA191279A (en) METHOD FOR PRODUCING 25,26-DIHYDROXYCHOLESTERINE
EP0537488A3 (en) Artificial standard and control sera, process for their production and use
FR2606281B1 (en) HEPATITIS B VIRUS ANTIGEN AND METHOD FOR THE PRODUCTION THEREOF
IT1096176B (en) HYDROCARBON RESINS, PROCESS FOR THEIR PREPARATION AND MEANS SUITABLE FOR THE PURPOSE
FR2345419A1 (en) PROCESS FOR OBTAINING 2,6-DI-TERT-BUTYLPHENOL
RO83468A (en) PROCESS FOR OBTAINING 5,6,7,7A-4H-TETRAHYDRO-TIENO / 3,2-C / -PIRIDIN-2-ONEI DERIVATIVES
DE69010608D1 (en) Process for the preparation of 1,1-diarylethanes.

Legal Events

Date Code Title Description
CC Supplementary certificate of protection laid open to the public (law of 25 june 1990)

Free format text: 92C0401, 920604

CC Supplementary certificate of protection laid open to the public (law of 25 june 1990)

Free format text: 92C0472, 920622

CB Supplementary certificate of protection granted (law of 25 june 1990)

Free format text: 92C0471, 790830

CB Supplementary certificate of protection granted (law of 25 june 1990)

Free format text: 92C0472, 790830

CB Supplementary certificate of protection granted (law of 25 june 1990)

Free format text: 92C0401, 790830

CL Concession to grant licenses